Omega Therapeutics Stock (NASDAQ: OMGA) stock price, news, charts, stock research, profile.
Open | $2.04 |
Close | - |
Volume / Avg. | 260.85K / 495.96K |
Day Range | 1.97 - 2.15 |
52 Wk Range | 1.30 - 6.30 |
Market Cap | $109.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 29.37% |
Days to Cover | 5.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Omega Therapeutics (NASDAQ:OMGA) through any online brokerage.
Other companies in Omega Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO) and FibroGen (NASDAQ:FGEN).
There is no analysis for Omega Therapeutics.
Omega Therapeutics has a consensus price target of $12.13.
The stock price for Omega Therapeutics (NASDAQ: OMGA) is $2.03 last updated Today at July 17, 2024 at 9:09 AM EDT.
There are no upcoming dividends for Omega Therapeutics.
Omega Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Omega Therapeutics.
Omega Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.